Synthesis of thromboxane B2 and prostaglandin F2 alpha by human platelets after contact with biomaterials used in vascular surgery
Pizzoferrato, A.; D'Addato, M.; Cenni, E.; Curti, T.; Cavedagna, D.; Tarabusi, C.; Cifiello, B.
Life Support Systems the Journal of the European Society for Artificial Organs 1(Suppl 1): 251-254
1983
ISSN/ISBN: 0261-989X PMID: 6336423 Document Number: 203471
Document emailed within 1 workday
Related Documents
Chiabrando, C.; Broggini, M.; Castelli, M.G.; Cozzi, E.; Castagnoli, M.N.; Donelli, M.G.; Garattini, S.; Giavazzi, R.; Fanelli, R. 1987: Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor Cancer Research 47(4): 988-991Tanaka, Y.; Yamamoto, T.; Matsumoto, T.; Sugiyama, Y. 1986: Detection of 6-keto-prostaglandin F1 alpha and thromboxane B2 in human placental tissues Nihon Sanka Fujinka Gakkai Zasshi 38(9): 1653-1654
Pratico, D.; Reilly, M.; Lawson, J.; Delanty, N.; FitzGerald, G.A. 1995: Formation of 8-iso-prostaglandin F2 alpha by human platelets Agents and Actions. Supplements 45: 27-31
Gao, J. 1989: Prostaglandin E2, F2 alpha,6-keto-prostaglandin F1 alpha and thromboxane B2 in the placenta of normotensive women and women with pregnancy induced hypertension Zhonghua Fu Chan Ke Za Zhi 24(6): 331
Stinger, R.B.; Fitzpatrick, T.M.; Corey, E.J.; Ramwell, P.W.; Rose, J.C.; Kot, P.A. 1982: Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha Journal of Pharmacology and Experimental Therapeutics 220(3): 521-525
Jeremy, J.Y.; Gill, J.; DuBourg, A.; Pelat, P.; Mikhailidis, D.P. 1993: Effect of buflomedil on in vitro prostacyclin and endothelin synthesis by vascular (rat and human) and penile (rat) tissue and calcium uptake by isolated human platelets International Journal of Impotence Research 5(3): 139-147
Aussel, C. 1984: Prostaglandin synthesis in human placenta and fetal membranes: partial inhibition by rat and human alpha-fetoproteins Research Communications in Chemical Pathology and Pharmacology 45(1): 157-160
Kaneko, N.; Masuyama, J-Ichi.; Nara, H.; Hirata, D.; Iwamoto, M.; Okazaki, H.; Minota, S.; Yoshio, T. 2002: Production of thromboxane A2 and prostaglandin i2 affected by interaction of heat aggregated IgG, endothelial cells, and platelets in lupus nephritis Journal of Rheumatology 29(10): 2106-2113
Basevich, V.V.; Mevkh, A.T.; Varfolomeev, S.D. 1984: Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets Biokhimiia 49(9): 1538-1545
Havel, M.P.; Griesmacher, A.; Weigel, G.; Owen, A.; Simon, P.; Müller, M.M.; Wolner, E. 1992: Aprotinin decreases release of 6-keto-prostaglandin F1 alpha and increases release of thromboxane B2 in cultured human umbilical vein endothelial cells Journal of Thoracic and Cardiovascular Surgery 104(3): 654-658
Watanabe, K.; Iguchi, Y.; Iguchi, S.; Arai, Y.; Hayaishi, O.; Roberts, L.J. 1986: Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase Proceedings of the National Academy of Sciences of the United States of America 83(6): 1583-1587
Hartung, H.P.; Hadding, U.; Bitter-Suermann, D.; Gemsa, D. 1983: Stimulation of prostaglandin e and thromboxane synthesis in macrophages by purified C3b Journal of Immunology 130(6): 2861-2865
Manuilova, I.A.; Murashko, L.E.; Asribekova, M.K.; Goncharova, V.N. 1983: Effect of 15-me-prostaglandin F2 alpha on the release of endogenous prostaglandin F2 alpha and the concentration of estrogen and progesterone receptors in the human endometrium Akusherstvo i Ginekologiia 1: 54-55
Zhang, M.L.; Ou, Y.A. 1989: Studies on the interrelation of plasma 6-keto-prostaglandin F1 alpha, thromboxane B2 and diabetic microangiopathy Zhonghua Nei Ke Za Zhi 28(3): 142-144; 185-186
Maurin, N. 1986: Routine measurement of thromboxane B2 and the prostacyclin metabolite 6-keto-prostaglandin F1 alpha in plasma Arzneimittel-Forschung 36(8): 1174-1179
Ylikorkala, O.; Kauppila, A.; Viinikka, L. 1981: Effect of cytostatics on prostaglandin F2 alpha prostacyclin, and thromboxane in patients with gynecologic malignancies Obstetrics and Gynecology 58(4): 483-486
Sakio, H.; Okuda, C.; Yoshida, Y.; Matsuzki, Y.; Said, S.I. 1981: Release of prostaglandins, especially prostaglandin F2 alpha and thromboxane A2 in experimental acute respiratory failure Masui. Japanese Journal of Anesthesiology 30(9): 933-939
Gao, W.X. 1993: Detection of plasma thromboxane B2 and 6-keto-prostaglandin Fl alpha in patients with recurrent aphthous ulceration Zhonghua Kou Qiang Yi Xue Za Zhi 28(2): 109-110
Bakinovskiĭ, L.V.; Gomtsian, A.R.; Baĭramova, N.E.; Kochetkov, N.K. 1985: Synthesis of oligosaccharide fragments of O-specific polysaccharides of Shigella flexneri. III. Synthesis of the tetrasaccharide Glc alpha 1-3Rha alpha 1-2(Glc alpha 1-3)Rha alpha 1-OMe and the pentasaccharide GlcNAc beta 1-2(Glc alpha 1-3)Rha alpha 1-2(Glc alpha 1-3)Rha alpha 1-OMe Bioorganicheskaia Khimiia 11(5): 655-661
De Clerck, F.; Beetens, J.; de Chaffoy de Courcelles, D.; Vercammen, E.; Freyne, E.; Janssen, P.A. 1989: R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule Progress in Clinical and Biological Research 301: 567-572